AI

Imbio and Riverain Technologies Collaborate to Provide a Comprehensive AI-Powered Lung Health Solution

Imbio | May 19, 2021

Imbio, a leading medical imaging artificial intelligence (AI) provider for chronic lung and cardiothoracic diseases, and Riverain Technologies, a leader in clinical AI for lung nodules, have announced a collaboration to provide clinicians, health systems, and radiology facilities with a more comprehensive lung health solution through a joint offering of their FDA cleared AI tools.

 

Riverain and Imbio also have scientifically proven thoracic imaging products that use machine learning and deep learning to assist clinicians in diagnosing lung diseases using digital data-driven tools.

 

Imbio is the first company that can provide fully automated quantitative analysis and 3D visualization of lung diseases like COPD, emphysema, and Interstitial Lung Diseases. The company's patented Functional Lung Density Analysis (LDAf) algorithm helps to visualize the components of COPD by providing a complete mapping of normal lung, air-trapping, and regions of chronic low density in a combined image, while their Lung Density Analysis Inspiration (LDAi) algorithm aids in the quantification and visualization of emphysema in low dose CT scans.LDAi also produces personalized reports for face-to-face patient communication, which can be used to educate people about their lung problems and help them quit smoking.

 

ClearRead solutions from Riverain Technologies include intelligent, enterprise-wide, standard-of-care AI tools for the early and effective diagnosis of lung nodules. Using patented suppression technology in thoracic CT and X-ray images, their ClearRead suite greatly enhances a clinician's ability to reliably and effectively diagnose disease for earlier, more efficient detection of lung abnormalities.

 

About Riverain Technologies

Riverain is committed to detecting lung disease as soon as possible. The opportunities for machine learning and software solutions in healthcare, according to Riverain, are at an all-time high. Never before has there been such a great opportunity to 'do more for less.' They believe that tools with increasing levels of intelligence can make decision-making easier, resulting in better patient outcomes.

 

About Imbio

Imbio is a leader in fully automatic AI image analysis for pulmonary and cardiothoracic conditions, both acute and chronic. Imbio's technologies improve physician productivity and patient care by transforming how patients are discovered, diagnosed, and treated. Imbio's solutions are completely automated, have received regulatory approval, and are available through their global partners.

Spotlight

The US health care system’s transition to value-based care VBC holds important implications for medical innovation. New value-based payment models shift financial risk from health plans to providers and other stakeholders, changing how they assess and adopt innovation. Performance measures and financial incentives in these payment models may encourage the use of therapies or technologies that save money in the short term or improve care as defined by a fairly narrow set of quality measures, potentially limiting patient access to innovation.

Spotlight

The US health care system’s transition to value-based care VBC holds important implications for medical innovation. New value-based payment models shift financial risk from health plans to providers and other stakeholders, changing how they assess and adopt innovation. Performance measures and financial incentives in these payment models may encourage the use of therapies or technologies that save money in the short term or improve care as defined by a fairly narrow set of quality measures, potentially limiting patient access to innovation.

Related News

HEALTH TECHNOLOGY

BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

BD | July 29, 2022

BD a leading global medical technology company, announced today it has acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. MedKeeper strategically complements BD's existing presence in the pharmacy – where the company has pioneered solutions in compounding, logistics workflow, controlled substance management and inventory optimization. MedKeeper's platform will become part of the company's existing portfolio of connected medication management capabilities. By combining MedKeeper's platform with BD's broad technology expertise, the companies will work to optimize the preparation of compounded medications – a critical need in the pharmacy today. "Preparing the right dose for patients requires a combination of factors – including personnel, training, and compliance. Pharmacy leaders require IV workflow management technology that is personalized to their needs and works within their environment. Adding MedKeeper to our portfolio will enable us to offer our customers easy to use, customizable solutions that make meaningful and incremental progress in IV workflow management." Mike Garrison, Worldwide President of Medication Management Solutions at BD Today, many pharmacies leverage a combination of both manual and technical tools for their IV workflow management system. Adding MedKeeper to BD's Medication Management Solutions portfolio will further strengthen the company's ability to deliver solutions that best meet customers' needs – now and in the future. "Demands in today's pharmacy environment, such as COVID-impacted labor shortages and changing regulatory requirements, have further exacerbated the need for customizable pharmacy software solutions to support flexible, directed workflow, inventory tracking and reporting needs in sterile and non-sterile compounding," said Garrison. "Manual, time-consuming procedures that might once have been 'good enough' now can be replaced and augmented by software that enables pharmacists to provide a higher standard of care." BD and MedKeeper will work to provide customers with flexibility and capabilities in meeting industry standards for preparing compounded medications, incorporating the latest regulatory guidance. Together, the companies are dedicated to ensuring that every customer has a workflow solution that best supports their environment and delivers efficiencies to their frontline clinicians. The transaction is expected to be immaterial to BD's fiscal 2022 financial results. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Read More

HEALTH TECHNOLOGY

HealthStream Acquires CloudCME

HealthStream | May 19, 2022

HealthStream a leading provider of workforce and provider solutions for the healthcare industry, announced the completion of its acquisition of the remaining equity interest of CloudCME, a Nashville-based healthcare technology company with a nationwide customer base. HealthStream originally invested in CloudCME in March 2019 when it purchased approximately 20 percent of the equity interest in the company. With its acquisition today of the remaining equity interest in CloudCME, HealthStream gains a best-in-class SaaS-based application for managing all aspects of continuing education within a healthcare organization. Across all healthcare organizations where patient care is delivered, many hours of CME/CE for physicians and clinical staff are mandated—with the amount and frequency required dependent upon state requirements and particular area of practice. The CloudCME application supports CME, CNE, CPE, Joint Accreditation, and many other credit types, including those designated via providership statuses or obtained via approving bodies. With this acquisition, HealthStream adds an essential application to its ecosystem for all of the critical workforce needs of healthcare organizations associated with CME/CE management. “As the founder of CloudCME, I am excited about this next level of growth for the company as part of HealthStream—with their ability to further support our customers with resources, great customer care, and innovation. Our commitment to excellent technology and customer service is strongly shared by HealthStream and I am, therefore, pleased that our customers will continue to receive the same outstanding service they’ve grown to expect from us over the years. I am also excited by the opportunity to join HealthStream in furtherance of our shared vision to ultimately improve the quality of healthcare.” Karl Wilkens, Chief Executive Officer, CloudCME Its user friendliness, intuitive design, and powerful capabilities have made CloudCME a leading application among healthcare organizations for CME/CE management and delivery. Healthcare organizations using CloudCME are provided with a branded web portal for all their CME/CE operations, as well as a branded mobile app for all of their users. A faculty portal provides quick access to all facets of faculty management, along with a robust content management feature for syllabi, faculty-uploaded presentation slides, PDFs, or videos. Pre-test, post-tests, as well as numerous reporting capabilities are among its many features and capabilities. An attendee portal for live CME/CE events streamlines administration and use for both the healthcare organization and the individual healthcare professional participant. “I want to warmly welcome all of CloudCME’s customers, users, and employees to HealthStream as we work together to continue supporting the delivery and management of quality CME and CE,” said Kevin O’Hara, Senior Vice President & General Manager, Platform Solutions, HealthStream. “The addition of CloudCME, coupled with our acquisition of Rievent Technologies at the end of 2021, establishes HealthStream as a market-leader for CME and CE management and delivery applications for healthcare organizations and their workforce.” About HealthStream HealthStream is dedicated to improving patient outcomes through the development of healthcare organizations’ greatest asset: their people. Our unified suite of solutions is contracted by healthcare organizations across the U.S. for workforce development, training & learning management, nurse & staff scheduling, clinical education, credentialing, privileging, provider enrollment, performance assessment, and managing simulation-based education programs. HealthStream’s corporate office is in Nashville, Tennessee.

Read More

HEALTH TECHNOLOGY

MedSec Sets Up a Healthcare Technology Cyber Risk Management Team

MedSec | July 04, 2022

In order to increase its biological and clinical knowledge, MedSec, a premier solutions provider of medical device security, announced it is forming a new Healthcare Technology Cyber Risk Management (HTCRM) team with a roster of seasoned professionals in the sector. The present Chief Product Officer of MedSec and HTCRM authority Phil Englert will take on the position of Advisor for the new team. "MedSec serves stakeholders of all kinds within the medical device eco-system. The establishment of this team allows us to better serve our hospital clients, who are tackling medical device security on a day-to-day basis." Justine Bone, CEO at MedSec "Biomedical and Clinical Engineering teams already have too many things on their plate – and they need leverage. Becoming an extension of their team, augmented by our technology capabilities, we're able to help our customers do things that they would otherwise not be capable of doing with their existing staff. Our clients love the combination of being able to 'speak tech' but also 'understand clinical' to help them further achieve their goals." Andrew Donarumo, Chief Technology Officer at MedSec Englert will continue to assist MedSec in creating security options for hospitals as an advisor. Englert brings to the position extensive understanding of clinical settings and medical technologies. His experience covers more than 30 years of technical and operational leadership in the healthcare and life sciences sector with an emphasis on creating strategic direction, enhancing operations, and undertaking business optimization and transformation efforts that are enabled by data and technology. In addition to governance and operations, vulnerability and patch management, incident response, medical device alerts, and SOC integration, Phil has led the development of medical device security programmes that have made it possible to prioritise strategic initiatives that will have an impact and carry out efficient maintenance and response tasks. In the past, he oversaw the development of strategy and tactics for a $250 million MedTech services business that supported over 130 Acute Care hospitals in 22 states.

Read More